Simplify Medical Pty Ltd. announced that data from three sites in the Company’s single-level Investigational Device Exemption (IDE) clinical trial evaluating the Simplify® Disc for total cervical disc replacement was selected as a Podium Presentation during the 2019 North American Spine Society (NASS) Annual Meeting, being held September 25-28 in Chicago, IL.
September 18, 2019
· 2 min read